# ATI Inc: financial statements, quarterly

ATI · NYSE · CIK 1018963 · [Materials](/sectors/materials.md) · fiscal year ends Dec 28

Pages: [Overview](/companies/ati.md) · [Financials](/companies/ati/financials.md) · [Filings](/companies/ati/filings.md) · [Insiders](/companies/ati/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ati/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,064](/filings/0001628280-24-006606.md) | [1,043](/filings/0001628280-25-021463.md) | [1,095](/filings/0001628280-25-036963.md) | [1,051](/filings/0001628280-25-046675.md) | [1,173 d](/filings/0001628280-26-010140.md) | [1,144](/filings/0001628280-26-028684.md) | [1,140](/filings/0001628280-26-054233.md) | [1,126](/filings/0001628280-26-068145.md) | [1,177 d](/filings/0001628280-26-010140.md) | [1,152](/filings/0001628280-26-028684.md) | [1,261](/filings/0001628280-26-054233.md) | [1,424](/filings/0001628280-26-068145.md) |
| Cost of revenue | $m | [858 d](/filings/0001628280-26-010140.md) | [846](/filings/0001628280-25-021463.md) | [868](/filings/0001628280-25-036963.md) | [826](/filings/0001628280-25-046675.md) | [924 d](/filings/0001628280-26-010140.md) | [909](/filings/0001628280-26-028684.md) | [898](/filings/0001628280-26-054233.md) | [870](/filings/0001628280-26-068145.md) | [904 d](/filings/0001628280-26-010140.md) | [889](/filings/0001628280-26-028684.md) | [951](/filings/0001628280-26-054233.md) | [1,044](/filings/0001628280-26-068145.md) |
| Gross profit | $m | [206 d](/filings/0001628280-26-010140.md) | [197](/filings/0001628280-25-021463.md) | [227](/filings/0001628280-25-036963.md) | [225](/filings/0001628280-25-046675.md) | [249 d](/filings/0001628280-26-010140.md) | [236](/filings/0001628280-26-028684.md) | [243](/filings/0001628280-26-054233.md) | [255](/filings/0001628280-26-068145.md) | [273 d](/filings/0001628280-26-010140.md) | [263](/filings/0001628280-26-028684.md) | [310](/filings/0001628280-26-054233.md) | [380](/filings/0001628280-26-068145.md) |
| Selling, general and administrative | $m | [92.3 d](/filings/0001628280-26-010140.md) | [82.0](/filings/0001628280-25-021463.md) | [88.9](/filings/0001628280-25-036963.md) | [82.4](/filings/0001628280-25-046675.md) | [89.0 d](/filings/0001628280-26-010140.md) | [85.0](/filings/0001628280-26-028684.md) | [82.8](/filings/0001628280-26-054233.md) | [94.6](/filings/0001628280-26-068145.md) | [103 d](/filings/0001628280-26-010140.md) | [92.1](/filings/0001628280-26-028684.md) | [95.7](/filings/0001628280-26-054233.md) | [108](/filings/0001628280-26-068145.md) |
| Operating income | $m | [108](/filings/0001628280-24-006606.md) | [115](/filings/0001628280-25-021463.md) | [143](/filings/0001628280-25-036963.md) | [142](/filings/0001628280-25-046675.md) | [209 d](/filings/0001628280-26-010140.md) | [147](/filings/0001628280-26-028684.md) | [161](/filings/0001628280-26-054233.md) | [162](/filings/0001628280-26-068145.md) | [171 d](/filings/0001628280-26-010140.md) | [164](/filings/0001628280-26-028684.md) | [220](/filings/0001628280-26-054233.md) | [272](/filings/0001628280-26-068145.md) |
| Income tax | $m | [(141) d](/filings/0001628280-26-010140.md) | [16.9](/filings/0001628280-25-021463.md) | [25.3](/filings/0001628280-25-036963.md) | [28.3](/filings/0001628280-25-046675.md) | [32.9 d](/filings/0001628280-26-010140.md) | [21.0](/filings/0001628280-26-028684.md) | [29.3](/filings/0001628280-26-054233.md) | [31.0](/filings/0001628280-26-068145.md) | [22.4 d](/filings/0001628280-26-010140.md) | [16.1](/filings/0001628280-26-028684.md) | [38.6](/filings/0001628280-26-054233.md) | [51.5](/filings/0001628280-26-068145.md) |
| Net income | $m | [146](/filings/0001628280-24-006606.md) | [66.1](/filings/0001628280-25-021463.md) | [81.9](/filings/0001628280-25-036963.md) | [82.7](/filings/0001628280-25-046675.md) | [137 d](/filings/0001628280-26-010140.md) | [97.0](/filings/0001628280-26-028684.md) | [101](/filings/0001628280-26-054233.md) | [110](/filings/0001628280-26-068145.md) | [96.6 d](/filings/0001628280-26-010140.md) | [118](/filings/0001628280-26-028684.md) | [151](/filings/0001628280-26-054233.md) | [190](/filings/0001628280-26-068145.md) |
| Diluted EPS | $ per share | [0.99](/filings/0001628280-24-006606.md) | [0.46](/filings/0001628280-25-021463.md) | [0.58](/filings/0001628280-25-036963.md) | [0.57](/filings/0001628280-25-046675.md) | not reported | [0.67](/filings/0001628280-26-028684.md) | [0.70](/filings/0001628280-26-054233.md) | [0.78](/filings/0001628280-26-068145.md) | not reported | [0.85](/filings/0001628280-26-028684.md) | [1.09](/filings/0001628280-26-054233.md) | [1.37](/filings/0001628280-26-068145.md) |
| Basic EPS | $ per share | [1.15](/filings/0001628280-24-006606.md) | [0.52](/filings/0001628280-25-021463.md) | [0.66](/filings/0001628280-25-036963.md) | [0.64](/filings/0001628280-25-046675.md) | not reported | [0.68](/filings/0001628280-26-028684.md) | [0.72](/filings/0001628280-26-054233.md) | [0.80](/filings/0001628280-26-068145.md) | not reported | [0.86](/filings/0001628280-26-028684.md) | [1.11](/filings/0001628280-26-054233.md) | [1.39](/filings/0001628280-26-068145.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [744](/filings/0001628280-25-007092.md) | [394](/filings/0001628280-24-019285.md) | [426](/filings/0001628280-24-035141.md) | [407](/filings/0001628280-24-044066.md) | [721](/filings/0001628280-26-010140.md) | [476](/filings/0001628280-25-021463.md) | [320](/filings/0001628280-25-036963.md) | [372](/filings/0001628280-25-046675.md) | [417](/filings/0001628280-26-068145.md) | [402](/filings/0001628280-26-028684.md) | [783](/filings/0001628280-26-054233.md) | [442](/filings/0001628280-26-068145.md) |
| Current assets | $m | [2,738](/filings/0001628280-25-007092.md) | [2,518](/filings/0001628280-24-019285.md) | [2,653](/filings/0001628280-24-035141.md) | [2,778](/filings/0001628280-24-044066.md) | [2,945](/filings/0001628280-26-010140.md) | [2,880](/filings/0001628280-25-021463.md) | [2,703](/filings/0001628280-25-036963.md) | [2,660](/filings/0001628280-25-046675.md) | [2,680](/filings/0001628280-26-068145.md) | [2,805](/filings/0001628280-26-028684.md) | [3,280](/filings/0001628280-26-054233.md) | [3,047](/filings/0001628280-26-068145.md) |
| Total assets | $m | [4,985](/filings/0001628280-26-010140.md) | [4,782](/filings/0001628280-24-019285.md) | [4,921](/filings/0001628280-24-035141.md) | [5,066](/filings/0001628280-24-044066.md) | [5,231](/filings/0001628280-26-010140.md) | [5,184](/filings/0001628280-25-021463.md) | [5,021](/filings/0001628280-25-036963.md) | [5,003](/filings/0001628280-25-046675.md) | [5,100](/filings/0001628280-26-068145.md) | [5,234](/filings/0001628280-26-028684.md) | [5,739](/filings/0001628280-26-054233.md) | [5,567](/filings/0001628280-26-068145.md) |
| Current liabilities | $m | [977](/filings/0001628280-25-007092.md) | [897](/filings/0001628280-24-019285.md) | [1,246](/filings/0001628280-24-035141.md) | [945](/filings/0001628280-24-044066.md) | [1,209](/filings/0001628280-26-010140.md) | [1,137](/filings/0001628280-25-021463.md) | [1,073](/filings/0001628280-25-036963.md) | [1,063](/filings/0001628280-25-046675.md) | [1,006](/filings/0001628280-26-068145.md) | [1,050](/filings/0001628280-26-028684.md) | [1,410](/filings/0001628280-26-054233.md) | [1,099](/filings/0001628280-26-068145.md) |
| Total liabilities | $m | [3,505](/filings/0001628280-25-007092.md) | [3,409](/filings/0001628280-24-019285.md) | [3,454](/filings/0001628280-24-035141.md) | [3,154](/filings/0001628280-24-044066.md) | [3,275](/filings/0001628280-26-010140.md) | [3,202](/filings/0001628280-25-021463.md) | [3,163](/filings/0001628280-25-036963.md) | [3,177](/filings/0001628280-25-046675.md) | [3,183](/filings/0001628280-26-068145.md) | [3,348](/filings/0001628280-26-028684.md) | [3,741](/filings/0001628280-26-054233.md) | [3,435](/filings/0001628280-26-068145.md) |
| Current portion of debt | $m | [31.9](/filings/0001628280-25-007092.md) | [27.1](/filings/0001628280-24-019285.md) | [317](/filings/0001628280-24-035141.md) | [27.9](/filings/0001628280-24-044066.md) | [180](/filings/0001628280-26-010140.md) | [180](/filings/0001628280-25-021463.md) | [179](/filings/0001628280-25-036963.md) | [192](/filings/0001628280-25-046675.md) | [31.1](/filings/0001628280-26-068145.md) | [33.2](/filings/0001628280-26-028684.md) | [384](/filings/0001628280-26-054233.md) | [49.7](/filings/0001628280-26-068145.md) |
| Shareholders' equity | $m | [1,373](/filings/0001628280-25-007092.md) | [1,264](/filings/0001628280-24-019285.md) | [1,355](/filings/0001628280-24-035141.md) | [1,791](/filings/0001628280-24-044066.md) | [1,850](/filings/0001628280-26-010140.md) | [1,873](/filings/0001628280-25-021463.md) | [1,743](/filings/0001628280-25-036963.md) | [1,707](/filings/0001628280-25-046675.md) | [1,805](/filings/0001628280-26-068145.md) | [1,771](/filings/0001628280-26-028684.md) | [1,877](/filings/0001628280-26-054233.md) | [2,005](/filings/0001628280-26-068145.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [417 d](/filings/0001628280-26-010140.md) | [(98.8)](/filings/0001628280-25-021463.md) | [101 d](/filings/0001628280-25-036963.md) | [24.0 d](/filings/0001628280-25-046675.md) | [381 d](/filings/0001628280-26-010140.md) | [(92.5)](/filings/0001628280-26-028684.md) | [162 d](/filings/0001628280-26-054233.md) | [230 d](/filings/0001628280-26-068145.md) | [316 d](/filings/0001628280-26-010140.md) | [128](/filings/0001628280-26-028684.md) | [132 d](/filings/0001628280-26-054233.md) | [155 d](/filings/0001628280-26-068145.md) |
| Capital expenditure | $m | [53.4 d](/filings/0001628280-26-010140.md) | [65.8](/filings/0001628280-25-021463.md) | [60.2 d](/filings/0001628280-25-036963.md) | [65.8 d](/filings/0001628280-25-046675.md) | [47.3 d](/filings/0001628280-26-010140.md) | [53.3](/filings/0001628280-26-028684.md) | [72.1 d](/filings/0001628280-26-054233.md) | [62.5 d](/filings/0001628280-26-068145.md) | [92.7 d](/filings/0001628280-26-010140.md) | [55.2](/filings/0001628280-26-028684.md) | [68.6 d](/filings/0001628280-26-054233.md) | [92.8 d](/filings/0001628280-26-068145.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [30.1 d](/filings/0001628280-26-010140.md) | [150](/filings/0001628280-25-021463.md) | [0.0 d](/filings/0001628280-25-036963.md) | [40.0](/filings/0001628280-25-046675.md) | [70.0 d](/filings/0001628280-26-010140.md) | [70.0](/filings/0001628280-26-028684.md) | [250](/filings/0001628280-25-036963.md) | [150](/filings/0001628280-25-046675.md) | [0.0 d](/filings/0001628280-26-010140.md) | [75.0](/filings/0001628280-26-028684.md) | [50.0 d](/filings/0001628280-26-054233.md) | [70.0 d](/filings/0001628280-26-068145.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [150](/filings/0001628280-23-015639.md) | [150](/filings/0001628280-23-026678.md) | [150](/filings/0001628280-23-036343.md) | [148](/filings/0001628280-25-021463.md) | [146](/filings/0001628280-25-036963.md) | [147](/filings/0001628280-25-046675.md) | [144](/filings/0001628280-26-028684.md) | [143](/filings/0001628280-26-054233.md) | [141](/filings/0001628280-26-068145.md) | [139](/filings/0001628280-26-028684.md) | [138](/filings/0001628280-26-054233.md) | [138](/filings/0001628280-26-068145.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 135,822,697 at 2026-10-26, from the cover of the [10-Q filed 2026-10-29](/filings/0001628280-26-068145.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 14:24 ET. No prices; not investment advice.